TherapeuticsMD, Inc. (TXMD)
Nasdaq: TXMD · Pharmaceutical Preparations · Boca Raton, FL · filing with the SEC since 1995
Who owns TherapeuticsMD, Inc.
As filed with the SECHolders of 5% or more
2
Baselake Partners, LP holds 6.8% of Common Stock, par value $0.001 per share, as its SCHEDULE 13G/A filed Aug 5, 2026 says.
Directors and officers
4
report now, of 26 people on the record since 2011. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Baselake Partners, LP
SCHEDULE 13G/A · filed Aug 5, 2026 · Common Stock, par value $0.001 per share · 5.2% in Apr 6, 2026
Clearline Capital LP
SCHEDULE 13G · filed Feb 12, 2025 · Common Stock, par value $0.001 per share
What TXMD reports owning in othersstakes of 5% or more, and other ties
2 subsidiaries in 1 country, from the list filed with the 10-K filed Mar 30, 2026.
Insider tradesForm 4
0sales
1purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2025 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 26 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Thompson Tommy G | Chairman | 0 | $0 | 0 | 1 | $0 |